#1babylon Analyst Day July 14, 2021#2Disclaimer Confidentiality and Disclosures This presentation contains proprietary and confidential information of Alkuri Global Acquisition Corporation ("Alkuri") and Babylon Holdings Limited ("Babylon") in connection with their proposed business combination. This presentation is for informational purposes only and is being provided to you solely in your capacity as a potential investor in considering an investment in Alkuri and may not be reproduced or redistributed, in whole or in part, without the prior written consent of Alkuri and Babylon. Neither Alkuri nor Babylon makes any representation or warranty as to the accuracy or completeness of the information contained in this presentation. The information in this presentation and any oral statements made in connection with this presentation are subject to change and are not intended to be all-inclusive or to contain all the information that a person may desire in considering an investment in Alkuri and are not intended to form the basis of any investment decision in Alkuri. This presentation does not constitute either advice or a recommendation regarding any securities. You should consult your own legal, regulatory, tax, business, financial and accounting advisors to the extent you deem necessary and must make your own investment decision and perform your own independent investigation and analysis of an investment in Alkuri and the transactions contemplated in this presentation. This presentation and any oral statements made in connection with this presentation shall neither constitute an offer to sell nor the solicitation of an offer to buy any securities, or the solicitation of any proxy, vote, consent or approval in any jurisdiction in connection with the proposed business combination, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdictions. This communication is restricted by law, it is not intended for distribution to, or use by any person in, any jurisdiction where such distribution or use would be contrary to local law or regulation. NEITHER THE SECURITIES AND EXCHANGE COMMISSION ("SEC") NOR ANY STATE OR TERRITORIAL SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE SECURITIES OR DETERMINED IF THIS PRESENTATION IS TRUTHFUL OR COMPLETE. In connection with the proposed business combination, Babylon has filed a registration statement on Form F-4 (the "Registration Statement") that includes a proxy statement and prospectus. The proxy statement/prospectus is not yet effective. The definitive proxy statement/prospectus, when it is declared effective by the SEC, will be sent to all Alkuri stockholders as of a record date to be established for voting on the proposed business combination and the other matters to be voted upon at a meeting of the Alkuri stockholders to be held to approve the proposed business combination and other matters (the "Special Meeting"). Alkuri may also file other documents regarding the proposed business combination with the SEC. The definitive proxy statement/prospectus will contain important information about the proposed business combination and other matters to be voted upon at the Special Meeting and is not intended to provide the basis for any investment decision or any other decision in respect of such matters. Before making an voting decision, investors and security holders of Alkuri are urged to read the registration statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC in connection with the proposed business combination as they become available because they will contain important information about the proposed business combination. Shareholders will be able to obtain a free copy of the proxy statement (when filed), as well as other filings containing information about Alkuri, Babylon and the contemplated business combination, without charge, at the SEC's website located at www.sec.gov<https://protect- us.mimecast.com/s/s1NYCmZ7VxuqZqqTGSqSa?domain=urldefense.com>. Alkuri and its directors and executive officers may be deemed to be participants in the solicitation of proxies from Alkuri's shareholders in connection with the transaction. A list of the names of such directors and executive officers and information regarding their interests in the business combination will be contained in the proxy statement/prospectus when available. You may obtain free copies of these documents as described in the preceding paragraph. This Presentation does not contain all the information that should be considered in the contemplated business combination. It is not intended to form any basis of any investment decision or any decision in respect to the contemplated business combination. The definitive proxy statement will be mailed to shareholder as of a record date to be established for voting on the contemplated business combination when it becomes available. Forward Looking Statements. Forward-looking statements include, but are not limited to, statements regarding Alkuri's or Babylon's expectations, hopes, beliefs, intentions, or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "strive," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These include statements about products still under development that have not been commercialized. You should carefully consider the risks and uncertainties described in the "Risk Factor" section of Alkuri's registration statement on Form S-1, the proxy statement/prospectus on Form F-4 relating to the business combination, which his expected to by filed by Alkuri with the SEC and other documents filed by Alkuri from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Alkuri and Babylon assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Neither Alkuri nor Babylon gives any assurance that either Alkuri or Babylon will achieve its expectations. Industry and Market Data. The data contained herein is derived from various internal and external sources. No representation is made as to the reasonableness of the assumptions made within or the accuracy or completeness of any projections or modeling or any other information contained herein. Any data on past performance or modeling contained herein is not an indication as to future performance. Alkuri and Babylon assume no obligation to update the information in this presentation. Further, these financials were prepared by Babylon in accordance with private company AICPA standards. Babylon is currently in the process of uplifting its financials to comply with public company and SEC requirements. Use of Projections. The financial projections, estimates and targets in this presentation are forward-looking statements that are based on assumptions that are inherently subject to significant uncertainties and contingencies, many of which are beyond Alkuri's and Babylon's control. While all financial projections, estimates and targets are necessarily speculative, Alkuri and Babylon believe that the preparation of prospective financial information involves increasingly higher levels of uncertainty the further out the projection, estimate or target extends from the date of preparation. The assumptions and estimates underlying the projected, expected or target results are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause actual results to differ materially from those contained in the financial projections, estimates and targets, including risks and uncertainties related to the combined business's ability to execute on its business strategy, attract customers, obtain regulatory approvals, scale its produce to compete effectively commercially, manage growth and costs, and the duration and global impact of COVID-19. The inclusion of financial projections, estimates and targets in this presentation should not be regarded as an indication that Alkuri or Babylon, or their representatives, considered or consider the financial projections, estimates and targets to be a reliable prediction of future events. IFRS Financial Statements. Babylon prepares its financial statements in accordance with international financial reporting standards ("IFRS") and not in accordance with accounting principles general acceptable in the United States. In addition, this presentation contains certain non- IFRS financial measures and key metrics relating to Babylon's historical and projected future performance. A reconciliation of these non-IFRS financial measures to the corresponding IFRS measures is presented where available, although the reconciliations are not presented on a forward-looking basis because the various reconciling items are difficult to predict and subject to constant change. Use of Non-IFRS Financial Measures. This presentation includes certain financial measures to evaluate Babylon's projected financial and operating performance, and measures calculated based on these measures, including adjusted EBITDA, that are not prepared in accordance with IFRS and that may be different from non-IFRS financial measures used by other companies. These non-IFRS measures, and other measures that are calculated using these non-IFRS measures, are an addition, and not a substitute for or superior to measures of financial performance prepared in accordance with IFRS and should not be considered as an alternative to operating income, net income or any other performance measures derived in accordance with IFRS. Babylon believes that these non-IFRS measures of financial results (including on a forward-looking basis) provide useful supplemental information to investors about Babylon. Additionally, to the extent that forward-looking non-IFRS financial measures are provided, they are presented on a non-IFRS basis without reconciliations of such forward-looking non-IFRS measures due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliations. Trademarks. Alkuri and Babylon have rights to various trademarks, service marks and trade names that they use in connection with the operation of their respective businesses. This presentation may also contain trademarks, service marks, trade names and copyrights of third parties, which are the property of their respective owners. The use or display of third parties' trademarks, service marks, trade names or products in this presentation is not intended to, and does not imply, a relationship with Alkuri or Babylon, or an endorsement or sponsorship by or of Alkuri or Babylon. Solely for convenience, the trademarks, service marks trade names and copyrights referred to in this presentation may appear with the TM, SMⓇ or symbols, but such references are not intended to indicate, in any way, that Alkuri or Babylon will not assert, to the fullest extent under applicable law, their rights or the right of the applicable licensor to these trademarks, service marks, trade names and copyrights. 2#3Today's Agenda Opening Remarks Rich Williams, CEO, Alkuri Global Babylon's Mission Dr. Ali Parsa, Founder & CEO Stakeholder Video Babylon's Clinical Advantage Darshak Sanghavi, MD, Chief Medical Officer Global Operations Stacy Saal, Chief Operations Officer Erin Lee, VP Global Operations Q&A: Global Operations (15 Minutes) 10 Minute Break Product Yon Nuta, Chief Product Officer Technology Steve Davis, Chief Technology Officer Dr. Saurabh Johri, Head of Al Q&A: Product & Technology (15 Minutes) 10 Minute Break Commercial Dr. Marcus Zachary, Head of Value Based Care Financials Charlie Steel, Chief Financial Officer Q&A: Full Executive Team (30 Minutes) Closing Remarks Dr. Ali Parsa, Founder & CEO 3#4Opening Remarks Rich Williams CEO, Alkuri Global 24/7 babylon Care that revolves around you Good morning Mathon how can help you?#5Why Babylon Health Is The Perfect Match For Alkuri Global A B C D E Alkuri's Investment Thesis Massive Total Addressable Market Artificial Intelligence-Led Disruptor Global Traction & Opportunity Scalability of Margins World-Class Team Notes: 1) Deloitte 2019 Global Health Care Outlook Report. 2) Defines profitability based on Adj. EBITDA. Adjusted EBITDA reconciliation in Appendix. Babylon Exceeds All of Alkuri's Acquisition Criteria $10T global healthcare market(1) that is ripe for disruption and shift to value based care Proprietary technology and Al poised to lead the transformation to Digital Health Services Proven global product-market fit and performance with demonstrated traction in the US ● ~166% revenue CAGR 2020A-2023E, improving unit economics and path to profitability in 2023E(2) Margin expansion over time through scale as expensive secondary care is replaced with cost-efficient primary care Gross margin scaling to ~23% by 2023E Visionary founder and talented management that knows how to grow and operate at scale 5#6Babylon has Grown From its Roots in the UK Healthcare Market to Become a Leader in Scalable, Digital-First, Value Based Healthcare ● 2013 Founded in 2013 ● Note: M=million. ● 2020 Rapidly scaling in the US through Babylon's digital-first VBC model 3M lives covered (~90k capitated) Licensed providers in 50 States Established leadership in UK digital healthcare Proved care model and benefits in a world class, but cost-constrained health system €: Proved utility of Al and digital health software in a range of care delivery environments via licenses to leading regional partners 2018 NHS PRUDENTIAL TELUS Mount Sinai Ascension CENTENEⓇ Corporation 2017 Demonstrated ability to deliver top-quality healthcare in a system with limited resources Proved ability to tailor the Babylon system to observe cultural priorities BILL & MELINDA GATES foundation babylon Poised for US Expansion > >>> Leading with Digital value based care High margin SaaS Software Licensing Scaling rapidly - 24M lives under coverage Global business - Focus on US Attractive margin improvement profile 6#7One of the Most Experienced Management Teams in Digital Health Founder & CEO Ali Parsa, PhD Circle Charlie Steel Goldman Sachs Founded and built Circle, the UK's largest privately- financed hospital chain and undertook an IPO into the London market Chief Financial Officer CILIC cmc markets Ran CMC Markets' IPO into the FTSE 250 Chief Business Officer Saurabh Johri, PhD Paul-Henri BREX COO Ferrand Yon Nuta Chief Science Officer Chief Product Officer DELL Centre for Outbreak Analysis MRC and Modelling Imperial College London President CMO & President 15 years of experience in developing Al for Healthcare Microsoft Served as one of the earliest CPOs of Xbox Chief Operating Officer Marcus Zachary, MD Stacy Saal Darshak Sanghavi, MD Global Lead of VBC Chief Medical Officer evolent HEALTH Assoc. CMO amazon Senior Medical Director Globally rolled out Amazon Prime and Amazon Fresh United Healthcare CMO, Medicare & Retirement CMO, OPTUM OptumLabs Chief Technology Officer SVP, Al & Data Erin Lee Steve Davis Samira Lowman VP of Global Operations oxpodia group Vrbo SVP & CIO VP, Tech & Product Director of Comm. Operations Product GStrategy & Operations Uber Chief People Officer Trillion PIDITAT CURATIONE VP, Talent & Acquisition & Development AMERICAN EXPRESS VP, Strategic Workforce Planning Today's speakers 7#8The Babylon Solution Ali Parsa, PhD Founder & CEO babylon We're here for you 24/7#9Putting an accessible and affordable quality health service in the hands of every person on Earth 9#10Understanding Babylon in 5 Questions. 1 2 How Do We Do It? 3 4 What Problem Are We Solving? 5 What Have We Accomplished? How Do We Monetize It? How Will We Grow? ● ● ● $10T global healthcare sector(1) has been unable to balance the needs of accessibility, quality and affordability Babylon's Digital-First Value Based Care (VBC(2)) offering seeks to align system-wide incentives Through the creation of a proactive, digital-first care network, which provides every member with a well structured "Care Pyramid," shifts the majority of member interactions to the mobile device and provides timely and targeted in-person care when needed We continue to scale at an impressive rate, with ~5x revenue growth in 2020, serving 24M lives across North America, Europe, Africa and Asia and delivering a patient interaction every 5 seconds (3) We have achieved 90% 5-star ratings (4) and demonstrated up to 35% cost savings (5) Through Clinical Services (taking the entire or proportion of medical cost of a population & capturing cost savings) & Software Licensing (selling technology to those who want to achieve similar results) Compelling financial model with 30%+ margins in clinical services & 90% + margins in software licensing (6) Expanding our existing service with our current customers into their wider operations and converting more of them to VBC (currently less than 1% penetration) Replicating existing model to new customers with the same needs in current markets & selective acquisitions Notes: T trillion. 1) Deloitte 2019 Global Health Care Outlook Report. 2) VBC - arrangement where providers are paid the total health budget for the managed lives. 3) Based on -2.0M clinical consultations (involving doctors, in virtual or physical setting) and -3.9M Al interactions (app interactions, including digital triage, health assessment) performed in 2020. 4) Based on patient survey in the UK, US and Canada for 2020-2021YTD. 5) Based on UK data, specifically for our UK GP at Hand (NHS) service. Babylon GP at Hand acute care cost per weighted patient in 2019/20 was compared to the North West London average in 2019/20, using NHS funding formulae to account for age, sex and other factors influencing health need. North West London is used as the comparator as Babylon GP at Hand is based in this area. 6) Based on a select software licensing contract. Gross Margin includes some technology costs that are classified as operating expenses in the company's financial projections. 10#11We Believe the $10T(1) Global Healthcare Sector has Been Unable to Balance the Needs of Accessibility, Quality and Affordability Value Quality Note: 1) Deloitte 2019 Global Health Care Outlook Report. Cost Accessibility + Affordability Clinical Quality 11#12Babylon Addresses Each of the Accessibility, Quality and Affordability Challenges with a Clear Solution Accessibility Digital-First Mobile Native Affordability Automation of Clinical Tasks - Operational Leverage for Clinicians Monitoring of Members - Reduce Crisis & Emergencies Clinical Quality Standardized Expertise Standardized Treatment Standardized Rehabilitation 12#13Babylon is Positioned to Unify and Empower the Two Critical Trends in Healthcare Value Based Care Movement away from broken fee-for-service model Aligns system around proactive care Not scalable traditionally X Challenge addressing many patient types Babylon is Scalable, Digital-First, Value Based Care X X Digital Health Leverages technology-driven efficiencies Bringing care to the patient vs patient to care Not scaled to address holistic care Shifts site of care vs addressing overall care and cost 13#14Creating an Alternative Using Scalable Digital-First Value Based Care $ Thousands 2) Revenue per Lives Covered (1) Hundreds $ $ Tens OAK STREET HEALTH one medical amwell Accolade Livongo (Pre-acquisition By Teladoc) Teladoc. HEALTH 100% Scalability(2) 200% babylon Digitally-Enabled Providers Capture significant share of health spend X Physical-first, brick and mortar models limit scalability X Limited technological capabilities Virtual Care Providers Digital-first models Scalable to most populations X Often specialized, limited care offerings X Lower revenue per user Notes: Axes are not to scale and based on management estimates. 1) Based on projected primary revenue contribution. Sourced from public filings unless otherwise stated. ONEM, OSH, and TDOC reflect FY20 revenue divided by the average of the current and prior year lives covered. TDOC FY20 Revenue pro forma for acquisitions. LVGO reflects FY19 revenue divided by average of FY19 and FY18 covered lives under diabetes management. ACCD reflects LTM revenue as of Q3 2020 divided by the average of Q3 2020 lives covered and lives covered in the S-1 as of December 2019. AMWL reflects FY20 revenue divided by current lives covered. Babylon reflects estimated revenue per life based active Babylon VBC contracts. Scalability defined as 2020A-2022E Revenue CAGR plus 2022E Gross margin. 2022E peer data sourced from Factset and CapIQ consensus estimates as of May 7, 2021, except LVGO FY20 and FY22 forecasts based on Factset consensus estimates as of August 4, 2020, one day prior to Teladoc acquisition announcement. TDOC FY20 Revenue proforma for acquisitions. Babylon financials based on management estimates. 14#15Babylon's Offering $ Thousands Revenue per Lives Covered $ Hundreds $ Tens Value Based Care Clinical Services We offer a broad spectrum of services Data OK, what symptom would you ko me to check? If you have more than one, tell me the symptom that's bothering you most Search for Secondary Care (1) 8 Digital Triage Insight (0) Virtual Consultations Healthcheck Goals < Overview Rehabilitation & Health Plan 56% -- Health Assessment Health program A Let's bette Colectie de 6.678 Plans Your care plan gedopodopped p | mk 20 manden v Track your p Digital Care Plan Monitor 9733 725 a 6550 Care Monitor Note: 1) Babylon takes on full financial responsibility for secondary care and utilises third-party partners to provide the appropriate treatment Lives Covered 52,000 ~2 million Illustrative Market: California Overview The complete solution: through our Babylon VBC service we manage the totality of patients' healthcare, including taking full financial responsibility for all costs incurred in secondary and tertiary care setting Through our clinical services and software licensing, we provide: o Babylon's full suite of Al and monitoring products o Care navigation and non-clinical support by live chat, phone or video o Virtual consultations with a clinical professional, for both urgent and chronic conditions 15#16Babylon is Providing Both Proactive Healthcare and Reactive Sickcare ● Insights and information about wellbeing Health goals and actions helping achieve the goals Health monitoring • Digital-first patient interactions keep the patient healthy ● Health Care 3. Insight 2. Data 4. Goals(¹) 1. Engage 5. Plan Note: These products are currently provided by Babylon unless specified otherwise. 1) In late stage of development. 7. Reward(¹) 6. Monitor Normalize If Abnormal ● ● ● ● Sick Care Access to the clinician team Right care, medication, and treatment as soon as needed Clear clinical care plan for treatment and recovery Health monitoring Monitoring Standard Rehabilitation Early Intervention Standard Expertise Treatment Standar 16#17Babylon's Solution Provides Every Member with a Well-Structured "Care Pyramid", Aligning Resources with Needs walle Dua Complex Care Referrals In Person Consultation The complete solution: Babylon manages the totality of a patient's healthcare, including taking full financial responsibility for all costs incurred in secondary and tertiary care setting Virtual Clinical Consultations Personal Health Assistant Digital Self-care Adds ongoing care: Preventive and proactive management to support ongoing primary and chronic care needs Adds clinical consultations: On-screen consultations with a clinical professional, both for urgent and chronic conditions Adds human touch: Care navigation and non-clinical support available by live chat, phone or video Digital Care Foundation: Babylon's suite of Al and monitoring products 17#18Timely, Highly Accessible Primary Care Enables Significant Cost Savings Engage Identification Contact & Education Healthcheck Office / ER Visit Digital Triage ! No Preventative Care or Health Education leads to repeat ER Usage or Office Visits No Established GP Relationship Patients often come to ER with minor problems Virtual Consultation Health Assessment Digital Care Plan ! Physical Consultation Office / ER Visit Care Monitor Care Monitor Cost Savings Babylon Checkpoint Physician Checkpoint Adverse Health Event Babylon Costs Traditional Healthcare Costs Time 18#19Babylon Has a Unique and Scalable Technology Stack Recognized for Excellence Clinical Care ---------- Ched Services (Admistrators) ========= 1) 2) 20 Enterprise h Integraten Developers 3 party Partners Clinical and back- office admin web portals Clinical Portal Member Operations Portal End Users Partner Portal Appointments Note FHIR Integration Platform is met Valide Apple Health SOK Remote Patient Monitoring Platform Clinical Process Automation Robotic Process Automation Platform Babton End 150 13485 Consultations Lab and Clinical Portal Platform Prescriptions Core EMR Functionality Electronic Medical Record System Experience Foundation (React Native) Notes Technology Stack Postan Workflow Scheduling GraphQL Federated API Platform/Experience Platform Triage & Symptom darity Feature Phone/SMS Plat (USSC) Build Sve St Messaging Q&A Channes A Response Conversation Platform Chat Data Integration Platform State Code Insights Experience Services Tenancy Kube Scanning E fog 3 Parter-app APT Innovative, Peer-Reviewed and Safeguarded by Suite of Patents Rewards Messaging Foundation Services (Cloud Native) Orchestration Containers Depy CCD Runtime Platform As A Service (Cloud Native) Connectors Canvas Data S on Cache Infrastructure As a Service (AWS) Babylon Advisor "I'm going to use it as a warning to machine-learning enthusiasts in the US - you're going to be made obsolete by companies in the UK" Judea Pearl, Turing Award-winner and professor of computer science at UCLA Monitor/Digital Partner Babylon Al Services Model of Medicine Probabi Al Brain / Platform Session Monitoring slering CON ------------... Cyber Security & Governance Heath Assessment Knowledge Secrets Logging Content Management Strategic Investments Clinical Health Record / Graph Platform Foundation Areas Medul Knowledge Management Disease Model Clinical Safety & Security Areas Capability Clinical Audit Engagement Workflow Management Knowledge Platform Fraud Delection Localization Management Epi D Management Prematu saluty ing Clinical Audit & Safety Pod market surullanca LifeCycle usion Detedion Case card management Check/Flow authoring Notes: Digital tools do not offer a diagnosis and references to diagnosis here are for research purposes only. 3 of the 43 pending patents have been accepted by US Patent & Trademark Office but not formally issued. Richens & Lee et al. "Improving the accuracy of medical diagnosis with causal machine learning". Management System DOOS Customer Data Platform Commerce / Finance Platform Hindsight Al development, monitoring and safety portals Data Science and Analytics Platform (Google Cloud Plato) Acquisition Application Firewalling HI! Al & Safety |4100|OW SUGU Markebeg/Ope • communications ● Patents Media coverage of Babylon's Peer-reviewed Al research MIT Technology Review nature 10 US Patents 43 US Patents Pending (1) 29 peer-reviewed papers published in leading journals Our peer-reviewed research demonstrated how diagnostic algorithms can be significantly improved through the application of counterfactual inference on causal models (2) frontiers in Artificial Intelligence Patents & Supportive Studies NEURAL INFORMATION PROCESSING SYSTEMS NewScientist A Association for the Advancement of Artificial Intelligence Advances in Approximate Bayesian Inference MultiVerse: Causal Reasoning using importance Sampling in Probabilistic Programming 19#20Our Technology is Licensed Across the Globe to ~15 Million People in Long Term Licensing Contracts ill Three WiFi Call 15:29 EN BM PRUDENTIAL pulse Temui pemeriksa simptom per anda 24/7 pada telefon anda powered by babylon MARI MULAKAN to see how you're doing Got it 4 How much time each week do you do moderate exercise like walking casual cycling or cleaning? Pulse App 1hr 40 mins-2hrs 30 mins OK, and what about intense exercise like running, mountain biking or boxing? 25-50 mins 3 Typing A 8 1 Home Check Symptoms Assess Health M 640 kcal Nasi Lemak with Fried Chicken Check Symptoms How can I help you, Christopher ? Upload your selfie Know your BMI 460% 23:5 A You need to.. jog for 1hour 45mins! What is influenza? influenza is a highly contagious respirato 10 Check Symp At Health C 10:00 Back ask App for NHS (Birmingham a&e and RWT) ... ask a&e Ok, what symptom would you like me to check? Enter a symptom eg headache 10:00 Back ask a&e This needs looking into, I symptoms would benefit further investigation or tr GP. I would advise speaking with a GP hours. If your symptoms worsen or y unwell in the meantime, seek medic more urgently. 17-M 14:18 We're here for you. How can we help? Check symptoms Looking after your mental health A breathing exercise can help You can do this quick and www breathing the cam The latest COVID-19 informatium and n th 64% 10:46 ||| TELUS Babylon by Telus Dr. Clara Moore dache all over, or mostly in of your head? headache start suddenly or is the pain? There's one area where it's most sore also noticed either eye to light or slurring of ch? ||| Eye sensitivity to light O Slurred speech Neither 0 < Gradually Moderate babylon by TELUS Health O 41 20#21Babylon in Numbers ~24M Members served by Babylon ~6M Patient Interactions in 2020 Scale Every ~5 Seconds Babylon Helps a Patient(1) ~105K Capitated Lives in the US(4) 16 Global Reach Countries where Babylon is Live 50 US States with Licensed Providers 8% Of UK Population Covered through COVID Care Assistant -14M Lives Covered in Developing Countries (5) 5x Growth In Annual Revenue(2) Growth 3M Covered Lives in the 1st Year in the US ~90K VBC Lives Added in First 6 Months (³) 6x Growth in US Provider Network(6) Notes: 1) Based on ~2.0M clinical consultations (involving doctors, in virtual or physical setting) and ~3.9M Al interactions (app interactions, including digital triage, health assessment) performed in 2020. 2) 2019A-2020A revenue based on unaudited historical financials. 3) As of April 1, 2021. 4) Includes VBC contracts active as of July 1, 2021. 5) Rwanda and South-East Asia. 6) 6x growth in provider and care team headcount over the past year (from January 2020 to January 2021). 21#22We Have Demonstrated Exceptional Accessibility, Quality and Affordability Across All Markets We Entered €/ 95% 4 and 5-Star Ratings (³) 95% Accessibility Clinical Quality Affordability 98% 4 and 5-Star Ratings(1) 90% Consultations Within 30 minutes (2) 80% Completion Rate of In-app Health Assessment (7) 102 Data Points Risk Assessment $430 34% Annual ER Cost Savings Per Member w/Digital Consults (11) Avoidance of ER/Urgent Care Visits w/Digital Consults (11) Retention (4) "Outstanding" CQC Awarded Ranking in Leadership 97% Up to 35% 25% NHS Quality Framework Pts in Clinical Domain Rate(8) Acute Care Savings(12)(13) Fewer A&E Visits(12) 91% 20% 91% 98% 55% 30%+ 4 and 5-Star Ratings (5) of Entire Population Registered (6) Clinical Audit Score(⁹) of Calls Answered Within 30 Seconds (10) Reduction in Unit Cost of Consultation (14) Savings on Clinical Consults (15) Notes: 1) For 2020-2021YTD. Includes ratings from our virtual care and Babylon VBC services. 2) For 2020 General Medical consultations. 3) 2019 to date for the UK business. 4) Babylon NHS data: In the first 3 months of membership, for patients who access a consultation, across 2020. 5) 2019-2020 data. 6) Based on 2.43M users registered as of February 2021. 7) -80% of 242 users who started the main health assessment flow went on to complete the main health assessment flow. Based on Home State Health Babylon VBC data for the period of October 1, 2020 - April 1, 2021. 8) NHS Digital: Quality Outcomes Framework (QOF) 2019/20. 9) Average across all 1,567 clinical audits in 2020. 10) Call center reports for January-February 2021 data. 11) Average saving resulting from a member having a digital consultation, given 34% of members surveyed say they would otherwise have visited ER or Urgent Care. Cost saving calculated under the assumption that the survey is accurate (assumes 80% adherence. i.e. 80% of the users who respond 'if I hadn't had access to Babylon's digital consultations offering then I would have gone to the ER' do not go to the ER following the consultation). Based on Babylon consultations data from all US Centene plans that have Alternative Health Choice (AHC) surveys as part of their consultation booking flow. The time period under consideration is January 2020 - February 2021. 12) Based on UK data, specifically for our UK GP at Hand (NHS) service. 13) Babylon GP at Hand acute care cost per weighted patient in 2019/20 was compared to the North West London average in 2019/20, using NHS funding formulae to account for age, sex and other factors influencing health need. North West London is used as the comparator as Babylon GP at Hand is based in this area. 14) From 2018 to 2020. 15) For Senior Nurse / GP consultations. In 2020, 32% of triage nurse calls were treated at the triage stage; 68% proceeded to Senior Nurse / GP consultations. 22#23Stakeholder Video#24Babylon's Clinical Advantage Darshak Sanghavi, MD Chief Medical Officer 13.30#25Babylon is Positioned to Unify and Empower the Two Critical Trends in Healthcare Value Based Care Movement away from broken fee-for-service model Aligns system around proactive care Not scalable traditionally X Challenge addressing many patient types Babylon is Scalable, Digital-First, Value Based Care X X Digital Health Leverages technology-driven efficiencies Bringing care to the patient vs patient to care Not scaled to address holistic care Shifts site of care vs addressing overall care and cost 25#26Babylon's Solution Provides Every Member with a Well-Structured "Care Pyramid", Aligning Resources with Needs 3. Insight 2. Data 4. Goals(1) 1. Engage Note: These products are currently provided by Babylon unless specified otherwise. 1) In late stage of development. Complex Care Referrals In Person Consultation Virtual Clinical Consultations Personal Health Assistant Digital Self-care 5. Plan 7. Reward (1) 6. Monitor Normalize If Abnormal Monitoring Standard Rehabilitation Early Intervention Standard Treatment Standard Expertise 26#27Using Patient Data and Insights to Create Personalized Care Plans 10:10 Engage overview Healthcheck activity ЧР nutrition k View report mood 8 Home Appointments Healthcheck Notifications Account Data Insights Gather patient insights Gather Data Goals Analyse data & insights Plan Engage Monitor Clinician creates a care plan 27#28Global Operations Stacy Saal Erin Lee Chief Operating Officer VP of Global Operations 13.80#29Using Our Operating Levers to Balance the Provision of Accessible, Affordable and Quality Healthcare Value Quality Cost Accessibility + Affordability Clinical Quality 29#30What is Digital-First and Why is it Important? ● Digital First is critical to accessibility Meeting our members where they are and being easily accessible at the first sign of a concern is critical in early detection and building high engagement Duck + Complex Care Referrals In Person Consultation Virtual Clinical Consultations Personal Health Assistant Digital Self-care 30#31Using Proven, Established Playbooks, Workflows and Automation to Support Our Members and Operators ● Operationalize the care pyramid end-to-end Scale to meet our tremendous growth prospects Improve Margins while maintaining quality of care Note: These products are currently provided by Babylon unless specified otherwise. 1) In late stage of development. 3. Insight 2. Data 4. Goals(1) 1. Engage Complex Care Referrals In Person Consultation Virtual Clinical Consultations Personal Health Assistant Digital Self-care 5. Plan 7. Reward(1) 6. Monitor Normalize If Abnormal Monitoring Standard Rehabilitation Early Intervention Treatment Standard Standard Expertise 31#32Driving More Segmented & Targeted Outreach to Engage Members 3 1 Risk stratify to inform outreach channels Risk Level Risk Low Med. High Engage Low Further segment risk categories to tailor messaging and outreach Medium High 1 Channels Persons 2 3 Data 4 High risk, pregnant member would receive messaging about prenatal care... 2 Insights Determine persons of members as we learn more through initial outreach Person 1: Adult male Person 3: Child with eligible parent 4 Test & iterate approach Test & Iterate Goals Person 2: Adult female Person 4: Child with ineligible parent Plan 20% Penetration % households signed up Home State Health - Illustrative Penetration Over Time Monitor 5 months HSH VBC penetrated(1) -20% (2) of member households in 5 months 1 year Time As of Q2 2020, Oak Street Health indicated less than 5% penetration (1) of total patients in its existing markets Source: Management reporting, Oak Street Health corporate presentation (October 2020). Notes: 1) Babylon defines penetration as the receipt of registration from a household in its covered population. Oak Street Health and other companies in our industry may calculate penetration and similarly titled measures differently, which could reduce the usefulness of penetration as a tool for comparison. 2) Within 5 months Babylon obtained at least 1 registration from 584 of 3,169 households in its assigned population. 32#33A Snapshot of Babylon's Global Operations UK Canada **** US Rwanda Cambodia Malaysia Singapore Notes: Statistics as of July 1, 2021. We have built a global footprint in 16 countries... Saudi Arabia Myanmar Thailand Laos Vietnam Hong Kong Taiwan Philippines Indonesia O 2M appointments since launch in Rwanda 99% of those surveyed would use the service again Licensing deals in 12 countries ~24M users have access to digital self-service tools 33#34A Snapshot of Babylon's Global Operations (Cont'd) UK Canada **** US Rwanda Cambodia Malaysia Singapore Notes: Statistics as of July 1, 2021. ...and clinical operations across 3 continents Saudi Arabia Myanmar Thailand Laos Vietnam Hong Kong Taiwan Philippines Indonesia Clinical Operations O ů ů 8M+ registrations globally and 6.5M+ covered lives in the US and UK ~105,000 US Babylon VBC lives in the US -100,000 Babylon GP at Hand members ~2M clinical consultations in 2020 Supported by 1,300 clinicians and 280 clinical admin staff 34#35Babylon has Built a 50-state Virtual Provider Network in the US Notes: 1) 2) 3) Babylon's ~200 providers and ~700 licenses (1)(2) in the US can support our 3M member population two times over State-licensed providers Clinical Service Offering 20 800 Do 8 Reduced recruitment to first consult time from 2 months → 2 weeks 6x growth in US provider and care team headcount over the past year(3) 3-4 licences (¹) per provider enables more efficient network coverage Highly selective recruitment process and selection criteria for clinician roles Average licenses per clinician = 3.6. Clinicians are defined as 'in-network' once they've passed Babylon's credentialing process. Babylon currently has 180+ clinicians who are active / live on the platform, the rest are currently going through onboarding or are inactive. January 1, 2020 to January 1, 2021 35#36Utilization Management: Ensuring Patients Receive the Care they Need from the Approriate Clinician Mix Members choose a symptom which is mapped to a clinician type, enabling faster access to the most appropriate clinician for their issue... 1) 2) Book appointment X What can we help with? } Cold and flu Runny nose, fever, aching, sore throat. Contraception Advice and prescriptions for contraception. Cough Dry, tickly or chesty cough. Mental health Feeling stressed, anxious or depressed. Muscles and joints Sources: Babylon GPaH data. Notes: Book appointment X Your appointment will be with Best for this kind of appointment. RECOMMENDED Prescribing Pharmacist Advice on all common illnesses and long-term conditions. Recommended if you have multiple conditions or illnesses. What they can do. Diagnosis, prescriptions, sick notes, referrals.. I want to see someone else Continue GP includes Dermatology GP. Other includes care coordinators, nurses, senior nurses, diabetic nurse specialists and travel health nurses. ...making a reality of multidisciplinary care Percentage of Digital Appointments by Clinician Type, % 1% 97% Sep-19 2% 11% 8% 78% Mar-20 5% 23% 27% 44% Sep-20 GP (1) Advanced Nurse Practioner ■ Pharmacist Physiotherapist (2) Other Appointment ratings have remained constant, with 95% or ratings scoring 4 or 5 stars 36#37Streamlined Onboarding Funnel to Deliver High Quality Clinicians Recruiting, Interviewing & Credentialing Robust yet efficient candidate vetting process ensures we select clinicians that will best serve our member populations 84% of our clinical workforce is employed through relationships Babylon has with professional corporations through a friendly PC model, 16% is our flexible workforce that allows us to scale on demand Highly selective recruitment process and selection criteria for clinician roles Clinical Onboarding Comprehensive training programs and a phased induction ensure that clinical staff only start active consultations after rigorous training Mock consultation Double appointments Peer review Close monitoring Probation review Ongoing review process Notes: 1) BMJ 2020 Leaders in Healthcare conference. Abstract published in the BMJ Leader Journal here. Ongoing Evaluation Continuous Monitoring Data-driven clinician quality management system has been recognised as industry leading (1) Regular Audits Comprehensive program of clinical audits drives clinician improvements with our directly employed and flexible workforce alike Notes Audits Video Consultation Audits Prescribing Audits Guideline Audits Physical Consultation Audits Support Team Phone Audits 37#38Our Clinicians are Provided with Advanced, Quality Tools Our Industry-Recognized (¹) Clinician Quality Dashboard... Do you need help with this dashboend? Click. Consultant ID La p babylon 4.3 44 15 35% Most recent data Jun 24, 2000 Total Appointments Dr Tat C Mar2020 ents Mar 2010 -Young You Cancellation Rate 3 Avgl Mar Rating 447 GP Apprent Apr 2020 1.5% For 2001 sp Apr 2025 Metric Definitions Starting 46 45 132 May 2010 Pate Appomers 439 14% Diagnosis Coding UK Clinician Performance Dashboard pa you 90% 92% Jun 2020 ++ Prescription Rate you 42% 41 Pr DIN Pandually Tous 23529 50% MY 25 Mar 232 You Avg Key Metrics Referral Rate you Appet Langh Total Canctions Cancellation Rate X you 1.3% [You Adjusted t 45 Punctually you 90% Mar 26 2020-242000 904 vd AbutedPuuty 31% May 2000 Score Jun 3000 coming soon Total 00:09:58 00:10:08 ↑↓ $1 ...allows clinicians to review their performance on demand, empowering them to understand and improve the quality of care and eliminating the need for clinical support teams to compile manual performance reports Our Suite of Performance Dashboards Allows us to Track Care Gap Closure Real Time QOF Performance Total QOF points Assuming all registers and quality improvement domains are met 600 500 200 100 1 Mar 19 1 Jul 19 GPH-Birmingham Indicator Performance GPaH-London preceding Syears AST007-Review and assessment within 12 months SMOKO02-Smoking status in the last 12 months HYP003 Age 79 or under, last HP 140/90mmHg or less AST006 Spirometry and other o objective test . 10% Care gap closure Most recent data for % achieved, number of patients met and missing within each indicator, ordered by number of patients missing cs005-Smaar performed in the last 3y6m aged 25-49 SMOKDO-Smoker offered support/treatment in last 24 BP002-Bleod pressure in SMOKOOS-Seoking advice/ referral to specialist DM019-Blood pressure 7% 140/90 mmHg or less 1 Mar 20 1420 SK 19% % patients achieved Count Achieved Consumer Network Subgroup 61% 1 Nov 20 ●67% 20K 15K 20K Patients Count Missing 1 Mar 21 1 Jul 21 176.4 Team responsibl GPaH- London GPH- Birmin gham 100% 50% 0% 0.00 LOON 50% 0% Total outstanding care gaps Total number of patients missing across all indicators 15 Note: 1) Presented at the BMJ 2020 Leaders in Healthcare conference (abstract was published in the BMJ Leader Journal: https://bmjleader.bmj.com/content/4/Suppl_1/A26.2). 30.000 0.00 20,000 10,000 QOF points achievement Bars show most recent % achieved within each indicator, relative to the minimum and maximum banchmarks for QOF point achievement. Max points available and points achieved shown as values Atrial fibi Indicator Group 1 Mar 19 Asthma 0.00 40 1 Sep 19 0.00 al 0.00 32 Date 0.00 AF006 04/04/2019 0.00 1 Mar 20 Blood pr Cervical essure screening 3.31 150 20 1.47 Data available up to 22/05/2021 Chronic obstructive pul 1 Mar 21 www 0.00 32.117 immary Year Over Year 39 10 0.00 10 0.00 W30A WCV ne State Health - HEDIS e Pulled by 2021 Data for April 2021 Ending Last Day of Month Prenatal Care Postpartum Cere Rule Name Annual Dental Breast Cancer Screening Controlling High Blood Pressure Cervical Cancer Screening Comprehensive Diabetes Care AIC TEST Comprehensive Diabetes Care AIC <9 Comprehensive Diabetes Care-EVE Comprehensive Diabetes Care BP (<140/90) Comprehensive Diabetes Care-HDAIC Control Chlamydia Screening ty Metrics ric is shown as a percentage of compliance to date in relation to an external benchmark value established by HSH (monthly and annual target) Childhood immunizations-Combo 10 Follow-Up After Hospitalization for Mental Follow-Up After Hospitalization for Mental Immunizations for Adolescents-Comboz Kidney Health Evaluation for Patients with Die Lend Screening in Children Use of Opioids from Multiple Prescribers Well Child Visits in the First 30 Months of Life Well-Child Visits in the First 30 Months of Life- Child and Adolescent Well-Care Visits Gaps 3.583 22 860 40 40 40 40 221 54 13 13 173 39 54 174 174 11 Total # of Care Gaps 9,293 108 50 3.539 Total # of Completed Care Gaps 926 Total # of Remaining Care Gaps 8,367 Care Gaps Complete 399 0 184 14 3 47 0 4 A 1 Z 11 86 0 73 Remaining 2020 Open Care.. Compliance 3.184 5 21 676 26 37 34 37 174 54 9 37 43 88 92 11 108 47 3.466 17% 11% 04 D% 21% 33% 1096 096 Null 43% 1046 Null 43% 99 9% 996 0196 896 196 69% 21% 17% 15% 20% 21% 294 36% 29% 62% 45% Null 0% 7% 0% 6% 22% BURNE 20% 20% 20% 20% 17% 119% 3849% 24% 27% 21% 30% 22% 22% 22% 35% 49% 30% 30% 36% 52% 50% 60% 59% 61% 61% 59% 58% 57% 64% 66% 66%6 66% 73% Care gap closure is monitored in an automated dashboard Progress on these externally validated indicators is tracked and compared to NCQC quality compass thresholds in the US and NHS national thresholds in the UK. 76% Patient-level care gap data is embedded into outreach and engagement tools to prioritise patients most in need of care. 89% 90% 89% 38#39Centralized Core Operations Supports Localized Babylon 360 Care Delivery Teams and Enables Rapid Deployment in New Markets Clinical Delivery Experience Operations Other Support Functions Centralized Core Operations Babylon 360 supported through digital first longitudinal care Primary Care Secondary and Tertiary Care General Medical Behavioral Health Care Management Clinical Support Provider Operations Patient Operations Support Operations Operations Analytics Marketing Finance Urgent Care HR Compliance Legal Commercial PMO Local Care Delivery Pediatrics Therapists Community Hith Workers Nurse Care Advisors Registered Nurses Family Practice Psychiatrists Outreach & Engagement Dieticians Local headcount informed by industry benchmark ratios adjusted to Babylon's digital-first model 39#40Improving Affordability Without Compromising Quality Care 1 Quality Health Outcomes Reduce avoidable secondary care visits (ER and inpatient days) High-quality primary care and increased engagement results in improved management of chronic conditions and reduce risk of exacerbations (referrals, ER and inpatient days) Quality Management: Systemic management of quality measures (e.g. HEDIS/STAR) 2 ပုံမှ Revenue Cycle and Network Management Risk Adjustment: Accurately coding members on annual basis and resetting coded baseline Quality Bonus: Payments for achieving and maintaining best-in- class clinical quality e.g. annual wellness visits Network Management: Developing & an appropriate partner and referral network; steerage to preferred appropriate sites of care and high- performing providers 3 8 Operational Cost Reduction Investing in automation of back- office activities and designing an outcomes-based platform that is built for scale Achieve truly multidisciplinary primary care (8) Leverage cutting-edge forecasting techniques and cross-state licensing technology to optimise the number of patients that each clinician can serve 40#41Babylon is Balancing Accessible, Affordable and Quality Healthcare Accessibility + Affordability Clinical Quality 41#42Q&A Global Operations Followed by 10 Minute Break#43Product Suite Yon Nuta Chief Product Officer 9:41 overview 00 t Healthcheck $ activity YP nutrition ill Report mood#44We are building Healthcare you want to use. 80 Goal achieved!#45What Our Members Get - Current Product Roadmap(1) Specific insights about their current and future health Truly tailored health goals and actions Proactive coaching, accessed on the platforms they already use - The right care at the right time - 24/7 – with follow-up, referrals, and pre- and post-hospital care when they need it Engage frequently, and be rewarded for doing so Note: 1) The product is under active development, has not been commercialized and we cannot guarantee if/when the product will be delivered to members. 45#46Babylon's Comprehensive Al Platform and Virtual Services Span the Entire Health Journey of our Members 10:00 Data OK, what symptom would you like me to check? If you have more than one, tell me the symptom that's bothering you most. Search for a symptom Digital Triage 10:00 Overview A Insight Healthcheck Activity thi Nutrition Healthcheck Mood Software Licensing < 10:00 Goals Overview 56% of your results meet national guidelines or are better than average 22% of your results need looking into 20% of your result suggest you are at risk 2% of your result pre-existing Hide detail Check your progress Actions View 10 actions you should take Understand your health 1 Health Assessment 10:00 Notes: 1) For members in the US who signed up between May 15, 2021 and June 11, 2021. Plans Your care plan Updated on 29 Feb 2020 Dr. Keith Grimes Diabetic Specialist Nurser in your appointment we discussed setting goals and actions that will help you achieve the lifestyle you want. Here is what we agreed. Have more healthy and balanced meals 1 action for this health goal Go for smaller plates in the house to reduce portions. Use the plates for dinner and for lunch meals. all. Add more exercise to your routine 2 actions for this health goal Walk 30 minutes everyday. Get off at Moorgate and walk to Liverpool street during the week, go to a park on the weekends Track your activity on the Monitor app Explore tools Self Care used by Over 40% of our Members(1) Healthcare Management Digital Care Plan 10:00 Mon Monitor Positivity n Activity Wed Thu Fri Sac Sun Tue Wed Thu 725 kcal Energy burned Monitor 9733 steps Average 10665 stops Energy Add Mood Fri Sat Sun Mon 6550 m Distance ☆ Body measurements. h Appointments Monitor ill Hammock 15k 10.06k Care Monitor Me Clincial Services Consult Refer Hospital Clinic POG Not Managed by Babylon Post Care Rehabilitation Parent Title Health program Let's beat the goal You set up your first goal for activity. If you need more questions consult your GP. Medication Collect your medicine Your medicine is ready to be collected at your local Pharmacy Activity 6,678 steps Average 10,130 Home 8 6 t • Appointments Healthcheck Notifications Me Sick Care Management 46#47Demo: Babylon 360 Digital-First Holistic Care Symptom Checker Engage Assess Our symptom checker provides an easy way to understand what are the likely conditions causing someone's symptoms, and more importantly, what are the potential next actions to be taken at that time. Our symptom checker is certified as a Class I medical device under European Commission Directive 93/42/EEC (MDD) and is compliant with 12 different standards as part of the certification. Plan Hi, I ask questions about your symptoms to help you find the right care, so you can feel better faster. Who needs my help? Me Someone else X Monitor Your results This is for information purposes only and does not replace medical diagnosis or advice. Some of the sym be checked out b 24 hours. Based on the infc matching conditic If symptoms pers seek a healthcare Inflammation c An inflammatio caused by irriti TA This usual provider w Viral tonsillitis An infection of throat, caused This usual provider wi Viral upper res A common vira Please note co similar sympto This usual provider w ← Viral upper respiratory tract infe... This usually requires seeing a family healthcare provider within 1-3 days. A common viral infection of the nose and throat. Please note coronavirus (COVID-19) could have similar symptoms to this disease. Why this could be a potential cause Some of your answers indicate that this condition could be the cause Sore throat Red throat Risks Typical symptoms Common treatment Warning signs Prevention Book an appointment Glandular feve A viral infection causing a fever, sore throat, and fatigue, often called "mono". This usually requires seeing a family healthcare provider within 1-3 days. Please note this is not an exhaustive list, so you may have a condition not listed here. If you are at all concerned or have questions about your health, please seek medical advice. Treat Book an appointment YOY Usage of Symptom Checker 2,500,000 2,000,000 1,500,000 1,000,000 500,000 Support ..... 2018 2019 2017 2020 2021 YTD 47#48Demo: Babylon 360 Digital-First Holistic Care Al Advisor Suggested Plans & Action Engage Assess Proprietary Al(1) will be able to monitor member data and automatically suggest to clinicians and members relevant and meaningful goals and actions, while keeping the clinician in the loop to lead to better health outcomes. Note: This example shows how we strive for meaningful suggestions that lead to positive outcomes. Research shows smaller plates tends to lead to reduced consumption which leads to weight loss. po a Van Woctors Window Helpı Health Graph Insights Patient data gathered from the Health Graph. Sources include: . . Health Assessment Monitor tracking data App interactions . Historical health records Weight from Monitor 115 110 105 100 95 90 140 2012 Blood Pressure from Monitor 130 2014 2016 Plan Date 2018 2020 Careplan recommendation Your objectives: Systolicbp 96.0 Diastolicbp 108.0 48 54 60 Bmi 16.0 18.0 120.0 20.0 MacBook Pro Patient value: 135.50 139.0 systolic BP Patient value: 85.76 diastolic BP bmi 25.0 90 Monitor 152.9 99 Patient value: 27.62 27.5 166.8 108 30.0 Note: 1) The Babylon Advisor product is under active development, has not been commercialized and we cannot guarantee if/when the product will be delivered to members. Clinical guidance . Check BP at least every 5 years Next Best Actions • Weight: REDUCE by 13.13 kg Send patient nudge Treat Support Emma Venkman Diabetic Specialist Nurse Go for smaller plates in the house to reduce portions. Use the plates for dinner and for lunch meals. See all your actions 48#49Demo: Babylon 360 Digital-First Holistic Care Monitoring: Delivering a 360 View of Your Health in One Place Engage Assess Babylon can connect with many third party wearables to monitor and provide a holistic view of our members' health. When we notice any abnormalities our team can be proactively alerted and intervene to understand the root cause and assessment via email, phone, or notifications. Plan < My data My health status The answers you gave during your health assessement have informed the health status below Alcohol Below national average Activity Below national average Mental health Incomplete, take the assessment All my data View by category Priority See all answers Smoking Stopped smoking Existing conditions 3 pre-existing Monitor Nutrition Incomplete, take the assessment Body measurements SI < 2:18 Steps avg 3385 steps Today 1696 steps Sun Mon Tue Energy burned avg 305 kcal Today 155 kcal Sun Mon Distance avg 2 mi Today 1 mi Home 20 Jun - 26 Jun Activity 1₁ Wed Thu Fri Tue Wed Thu Fri 1 Monitor Healthcheck Sat Sat Treat 4K 2K 200 Profiles Status 9:41 AM Not active Activity Support Risks Here are some changes you can make that could improve your activity. *100% Cardio You're below national guidelines Strength You're below national guidelines Balance You're just below national Active 49#50Demo: Babylon 360 Digital-First Holistic Care Easily Book Live Appointments When Necessary... Engage Assess Book appointments up to 24/7/365. For Primary Care, Behavioral Health, or specialists' synchronous appointments via Video or Audio. In the most convenient way possible: 87% of appointments happen within 30 minutes of booking. A further 5% happens in the next 48 hours or as requested by the member. Babylon Care Management Team: Care Advisor, Community Health Worker, Engagement Coordinator, Social Worker, Registered Nurse, Dietitian, Behavioral Health Counselor, Quality and Performance Manager, Administrative Support Plan 9:41 AM Select appointment type What can we help with? 9:41 Mental health Stress, anxiety or feeling to a physician, get a pre sign up for therapy. Urinary problem Pain or burning when ur needing to urinate ofter Cough Dry, tickly or chesty cou Heart concerns Blood pressure, choles other heart health que: * 100% Cold and flu Runny nose, fever, hea sore throat. X Monitor $03³ :०Co Treat A Support Babylon's Virtual Services Behavioral health care Therapy and psychiatry services Primary care Ongoing management of primary care needs Outside of Babylon's Virtual Services (managed / overseen by Babylon Care Team) Prescriptions, labs, imaging, immunizations Any prescriptions / testing / immunizations that are ordered by a Babylon virtual provider In-person primary and specialty care Referral to identified network of providers / clinics for in-person care when needed Urgent / emergency care Referral to in-person care when there is an urgent need / emergency 50#51Demo: Babylon 360 Digital-First Holistic Care Or Handle Common Medical Issues Conveniently... Engage Assess Many clinical needs don't require an appointment. Simple tasks like dealing with a UTI or Prescription Renewals can happen asynchronously using our proprietary scalable platform. Currently we have asynchronous flows for contraception medications, urinary tract infections (UTI) and repeat prescriptions. 9:41 Plan Book appointment Do you have any of the following conditions? Antiphospholipid syndrome (APS) Diabetes Inflammatory bowel disease (IBD) Long term mobility problems Migraine Rheumatoid arthritis Systemic lupus erythematosus (SLE) None of the above X Monitor STARK, Sansa 09 Apr 1999 (21) 50 Sloane Avenue Ltd, 50 Sloane Avenue +44 7700900292 Gender: Female Patient ID: 412 5980 GP AT HAND LONDON NHS West London Consultation ID: 848 386 28 Oct 2020, 12:50 Preparation Alert Presenting complaint Patient summary Patient history Patient details. GP details Examination Diagnosis Actions M+1 > 8+2 M+2 WHE Review consultation Windo Ready to call 0:00:00 Revoke recording consent. Mark as no show Treat Pre-consultation questionnaire 5 days ago, 28 Oct 2020, 11:20 What would you like to do? Start contraceptive pills • Review and reorder current pill • Switch to a different pill Other contraception or advice Switch to a different pill To prescribe safely, we need to ask you some health questions. It should only take a few minutes. You'll need: Your height and weight A blood pressure reading from the last two weeks You can check your blood pressure at some pharmacies for free or for a small fee. Or you can buy a clinically-validated blood pressure monitor. You can read how to get a blood pressure reading at: https://support.gpathand.nhs.uk/hc/en- us/articles/360009929878 Continue We base our advice on your answers. For your safety, all your answers must be accurate to the best of your knowledge. Incorrect information can cause harm I understand What's the top number on your blood pressure reading? This is your systolic blood pressure (SYS), for example 120. 150 What's the bottom number on your blood pressure reading? This is your diastolic blood pressure (DIA), for example 80. MacBook Pro Support Show introduction to pre-consultation questionnaire Clinicians can review and sign off the results asynchronously 51#52Demo: Babylon 360 Digital-First Holistic Care Allowing Clinicians to Spend More Time with their Patients Engage Assess A leading NLP engine will auto-transcribe clinician interactions in real time and generate meaningful notes and summaries about interactions (1) This matters because: Reduce administrative burden for clinicians ● Creates more accountability and transparency reducing costly errors Build structured data set that enables future Al solutions Plan babylon SMITH, Sarah 1 April 1983 (37) [email protected] Gender: Female Patient ID: 101 371 34 NHS CCG Consultation ID: 332 358 7 Apr 2020, 10:00 Preparation Alert De Partient Summary Presenting Complaint Patient History Patient Details GP Details Examination Diagnosis Actions > 28+1 M+2 Wastar Window 2 Halp Monitor Revoke recording consent Note: 1) The feature is under active development, has not been commercialized and we cannot guarantee if/when the product will be delivered to members. | EXAMINATION Auto notes Needing to go to the toilet more often than normal, feeling like need to go every hour, passing urine 6-7 times/day. No stinging when pee, pee is coming out a bit pink as if some blood in it. No blood in urine. Lower abdo ache. No cloudy pee. Feels like pressure on bladder. Pain only when peeing. Similar to previous UTI's Last UTI was 2 years ago. PMH: IBS MacBook Pro Treat Consultation notes Your notes 10:00 Support 52#53Technology Technology Platform Steve Davis Chief Technology Officer 13.80#54Babylon's Unique Platform Centric Approach Enables a Highly Scalable Solution Enabling Analog To Digital Care Delivery Acceleration Clinical Care Doctors Clinical Services (Administrators) Enterprise Users (Administrators) Integration Developers 3rd party systems Partners 1 I I I Clinical and back- office admin web portals Clinical Portal Member Operations Portal Partner Portal End Users Validic HIPAA Appointments Consultations Apple Health FHIR Integration Platform Notes ISO 27001 Remote Patient Monitoring Platform Clinical Process Automation Lab and Tests Clinical Portal Platform Babylon End Users SDK Robotic Process Automation Platform ISO 13485 Experience Foundation (React Native) Notes iOS Electronic Medical Record System Penetration Testing Workflow Android Scheduling Prescriptions Core EMR Security Information & Event Management GraphQL Federated API Platform / Experience Platform Live Chat Triage & Symptom Identity Build Svcs Storage Web Feature Phone / SMS Platform (USSD) Channels Static Code Analysis Feature Phone Insights Data Integration Platform Q & A Ai Response Conversation Platform Tenancy Orchestration / Runtime Kube Async Messaging Experience Services Goals Vulnerability Scanning White-label apps Containers Intent Stream Connectors Rewards Log Aggregation & Analysis API Messaging Foundation Services (Cloud Native) Canvas SDK Session Deployment automation Platform As A Service (Cloud Native) Partner End Users Data Svc Babylon Advisor CI/CD Cache Infrastructure As a Service (AWS) Privacy Controls and Governance Partner-app integrations Partner API Monitor / Digital Twin Babylon Al Services Model of Medicine Probabilistic Graph Al Brain / Platform Session / Access Virus & Malware Scanning Cyber Security & Governance Monitoring / alerting CDN Health Assessment Authorisation Knowledge Extraction Secrets Logging Clinical Health Record / Graph Secrets Authenti- cation Encryption in Transit (TLS 1.2) Strategic Investments Engagement Content Workflow Management Management Medical Localization Knowledge Management Management Disease Model Epi Data Management Management Knowledge Platform Clinical Audit Capability Platform Foundation Areas Clinical Safety & Security Areas Pre-market Post-market safety testing surveillance Clinical Audit & Safety Fraud Detection Encryption at Rest (ASE256) LifeCycle Customer Data Platform Case card management Intrusion Detection Check / Flow authoring Model Management System Hindsight Al development, monitoring and safety portals Commerce / Finance Platform Acquisition Data Science and Analytics Platform (Google Cloud Platform) DDoS Prevention Application Firewalling I 1 I I T I I T I I I I T I I Al & Safety Al Scientists. AI doctors Epidemiologists Clinical Safety Team Marketing / Ops Business Analysts Applied Research. Engineering & Product 54#55Global Scale Operating in 16 Countries and 11 Languages Covering Millions of Lives Babylon's Cloud Regions Canada US EU Singapore Why Does This Matter? Global scale can be challenging - we have found a solution for this Our goal is to deploy rapidly into any region in five days or less. Data Sovereignty is a requirement by many countries which we are delivering on 55#56Accessible and Affordable can be Challenging - Our Unique Approach Through Multiple Channels Enables Global Coverage at Scale Clinical Care Doctors Clinical Enterprise Users (Administrators) Integration Developers 3rd party systems Accessibility can be challenging, Babylon's unique approach through multiple accessibility channels enables global coverage to the least developed nations and the most modern smart phones Clinical Safety & Security Areas 9:41 Overview Chris, 65/100 of your results meet national guidelines or are better than average. ♡ A P ▸ BC 65% healthy Medical history HIPAA 20% average Body View the health of 15 of your organs Disease risk View your risk of 20 diseases Actions View 5 actions for staying healthy ☎ 15% unhealthy 5.9% of your organs are affected by pre- existing conditions Fa * D 8 M Home Appointments Healthcheck Notifications Account "Smart Phone" Robode PrO0 ISO 27001 Its Partners Experience Foundation Automation ISO 13485 Lab and Tests ical Portal Am s Automation Platform Experience (Rea Notes hic Medical Re Prescriptic MTN Penetration Testing Your appointment is scheduled for today at 11:45am with Nurse Patricia. Please make sure your phone is turned on at this time. 0. Back to menu Reply Feature Phone / SMS USSD) Build Svcs Smart Security Information & Event Management Cancel ed API Platf Static Code Analysis Q & A Al Respor nversation USSD Service.be "Feature Flip Phone" Orchestration / Runtime Async Messagi experience latform Goals API Foundat Vulnerability Scanning Stream 9:41 Monitor Get out and about Regular exercise is great for your physical health and your mental wellbeing. Infrastru Mood Mon Tue Wed Thu Fri Sat Sun Log Aggregation & Analysis • Positivity Energy Containe Home Appointments Monitor Healthcheck Account Platform As A Service (Cloud Native) BCS Add Mood Activity 6,678 steps Average 10,130 High M Dig ylor Model Privacy Controls and Governance Pro Brai ession ccess Data Svo ache "Partner Application" nitori alertin Virus & Malware Scanning Cyber Security & Governance CDN Authorisation Strategic Investments Why Does This Matter? Great companies deploy weekly to the Apple Store - our approach enables this Secrets • Accessibility for all can be challenging, not everyone has a smart phone Authenti cation Our embeddable 'Canvas' layers provide partners the ability to rapidly embed our AI services Encryption in Transit (TLS 1.2) Data Science and Analytics Platform (Google Cloud Platform) Encryption at Rest (ASE256) Safety Detection DDoS Prevention Application Firewalling Applied Research Engineering & Product 56#57Deeply Coupled Process Automation Solving for Driving Efficiency in Our Care Pyramid Delivery Babylon Clinical Portal I Health Graph & Al Platform Workflow Robotic Process Automation Babylon Member App ● ● ● Why Does This Matter? Optimization in the reduction of manual tasks eliminates friction for our members Advanced automation drives efficiency and scale globally to free up time for our clinicians Accelerators allow for rapid deployment into new countries, markets and partners 57#58Standards-based Integration Platform Enabling Massive Data Collection Fuelling Our Al Platform / Services Strategy Electronic Health Records Babylon Clinical Portal Babylon Member App Wearables FHIR HL7 Integration Service Health Graph & Al Platform Labs Healthcare Organizations Why Does This Matter? Solves for unique country by country integration challenges Built on proprietary open source services for rapid scale Real-time streaming data collection at massive scale Data productized in real-time powering Al services 58#59Technology Al Platform & Services Saurabh Johri, PhD Chief Science Officer 13.80#60The Babylon Brain: Al Technology for Healthcare Clinical Knowledge Perception Deep Learning Causal Al Digital Encyclopaedia of medicine encoded SNOMED, ICD-N via FHIR NLP to process, structure & extract member information from EHR & Claims, and to automate clinical tasks Delivering deep, data-driven insights from the Babylon's proprietary health graph Proprietary, next-generation Al, delivering interpretable & explainable Al Center of Al & Scientific Excellence Bench of 35 deep experts in Al & Population Health applying thought leadership to solve real-world problems Al research Scientists, Population Health Research Scientists, Population Health Data Scientists Over 50% with PhD 60#61The Babylon Brain: Al Technology for Healthcare (Cont'd) Note: These products are currently provided by Babylon unless specified otherwise. 1) In late stage of development. 3. Insight 2. Data Goals (¹) 1. Engage 5. Plan 7. Reward (¹) 6. Monitor Normalize If Abnormal Monitoring Standard Rehabilitation Intervention Early Standard Expertise reatment Standard 61#62Al: Enhancing Every Step of Our Members' Care Data Collection Under Active Development(1) Health Assessment Deep Patient Understanding Healthcare Loop Advisor Clinician in the Loop NLP Real Time Dynamic Risk Scheduling Computer Vision Triage Sick Care Loop Note: 1) The Babylon Advisor, Real Time Dynamic Risk and Deep Patient Understanding features are under active development, have not been commercialized and we cannot guarantee if/when the product will be delivered to members. 0.0 000 1888 *** 62#63Causal Al for Transparent Decision Making Regional Risk Factor Prevalence Relative Risk Epidemiological Research Regional Disease Incidence Population Health & Epidemiological Research Disease-Observation EHR (Internal & 3rd party) Claims records SME opinion D R O R D R Risk Factors Diseases Observations 63#64Causal Al for Transparent Decision Making (Cont'd) ← Do you also have a fever? Yes No D R R D R Risk Factors Diseases Observations 64#65Causal Al for Transparent Decision Making (Cont'd) Health Graph Immunosuppressed Gastroenteritis D R O R D R Risk Factors Diseases Observations 65#66Al: Connecting Every Step of the Member Journey 12:48 C ← Have you experienced any difficulty breathing? See an explanation ☐ - ■ ■ ■ I'm finding it harder to breathe than usual 479% I wake up at night gasping for breath I find it difficult to breathe when lying flat None of the above I don't know X Symptom Checker 9:41 < Your blood sugar is higher than average. You're in the amber zone ● Normal <140mg/dl all 140-199 mg/dL High >200 mg/dL İİİİİ 3 out of 5 members with your BMI or higher, also have a higher than normal blood sugar. This may mean you are at higher risk of develop diabetes in the future. What's next? Health Assessment 9:41 < Sorry you're getting a cough, would you like to send a change request to Dr. Miller. Lisinopril Losartan Here is our suggestion: Recommended for you all? Losartan 50mg Cough Take once daily. 37% less likely to cause cough than Babylon Advisor(1) Note: 1) The Babylon Advisor and Proactive Recommendations features are under active development, have not been commercialized and we cannot guarantee if/when the feature will be delivered to members. 170/90 BP is trending up. Let's find out why Proactive Recommendations (1) 66#67Our Technology is Well Protected & Recognized for Excellence ● ● Patents & Supportive Studies Patents 1) 2) 10 Granted (all in US) Innovative, Peer-Reviewed and Safeguarded by Suite of Patents 43 Pending applications (1) ● • 29 peer-reviewed papers published in leading journals Our peer-reviewed research demonstrated how diagnostic algorithms can be significantly improved through the application of counterfactual inference on causal models(2) Media coverage of Babylon's Peer-reviewed Al research MIT Technology Review An algorithm that can spot cause and effect could supercharge medical Al "I'm going to use it as a warning to machine-learning enthusiasts in the US - you're going to be made obsolete by companies in the UK" Judea Pearl, Turing Award-winner and professor of computer science at UCLA frontiers in Artificial Intelligence A Comparison of Artificial Intelligence and Human Doctors for the Purpose of Triage and Diagnosis Notes: Digital tools do not offer a diagnosis and references to diagnosis here are for research purposes only. 3 of the 43 pending patents have been accepted by US Patent & Trademark Office but not formally issued. Richens & Lee et al. "Improving the accuracy of medical diagnosis with causal machine learning". IA rating overlapping datasets bivariate causal discovery Association for the Advancement of Artificial Intelligence nature communications Improving the accuracy of medical diagnosis with causal machine learning NewScientist Al mimics the way doctors think to make better medical diagnoses Advances in Approximate Bayesian Inference MultiVerse: Causal Reasoning using importance Sampling in Probabilistic Programming NEURAL INFORMATION PROCESSING SYSTEMS Neural poral Point Processes for Modelling Electronic Health Records 67#68Q&A Product & Technology#69Commercial Marcus Zachary, MD Head of Value Based Care 13.30#70We Have a Strong Pipeline of New Contracts Worldwide Projected ARR(1) Pipeline Coverage (2) 1) 2) Deal Count Upselling Existing Clients ~$1.2BN -98% VBC 2.5x ~15 ~55% VBC New Clients -$2.4BN ~99% VBC 5.1x ~35 -55% VBC Source: Based on management estimates and a pipeline of contracts under discussion as of March 15, 2021. Notes: ARR (Annual Run-Rate Revenue) at the end of a given month is calculated at a point in time by multiplying that month's expected revenue by 12. Multiple of estimated December 2021 Annual Run-Rate Revenue of ~$475M. Total Pipeline ~$3.6BN ~99% VBC 7.6x -50 -55% VBC 70#71Our Current Commercial Strategy Where are we selling? US Europe Asia What are we selling? Babylon Cloud Services Digital Self-care Babylon 360 Complex Care Referrals Primary & Chronic Care Management Clinical Consultations Personal Health Assistant Digital Self-care 1 Who are we selling to? Providers 2) Payers 2 1 Health Plans (Medicaid, Medicare, Commercial, Self-Insured) Integrated Health Delivery Systems 3 Employers (self-funded) 71#72We Have a Multidisciplinary Team to Deliver Our Strategy GTM Ops & Insights Strategize and plan Manage process and people Provide commercial, marketing and product analytics ● ● ● Marketing Manage brand end- to-end Engage members Manage customer relationships ● ● Comms Manage strategic comms Own public relations Liaise social media activities ● ● Business Development Babylon 360 Babylon Cloud Services US Payers, Providers, Employers, etc. APAC Providers, Telco, Pharma, D2C (tbc) UK Payers, Providers, Employers, etc. Social Impact NGOs, Providers, Telco, etc. Shape our growth strategy Build and grow revenue streams Maintain strong client relationships Revenue Centres 72#73How We Establish New VBC Contracts Client Need: Understand problem that client is trying to solve ● ● Identify Opportunity ● Identify best suitable population and get insights into condition modifiability Fit with Babylon 360: Confirm how Babylon 360 can solve the problem Statistical Data and Assessment: Receive historic claims, medical and population data from client ● ● Assess Risk ● Aggregate and analyze data to understand current cost base, population conditions, etc. Model impact of Babylon's services on potential population Establish Economics Economics: Assess and agree on economics that work for both parties Recourse: ● Reinsurance to limit downside risk 73#74Case Study: Rapidly Scaled and Reduced High Cost Care Utilization by Centene HSH Members Babylon has Achieved Rapid Engagement with the Home State Health (HSH) Member Population... Home State Health - Illustrative Penetration Over Time Penetration 20% 5% % households signed up 2) 3) 4) 5 months HSH VBC penetrated (1) -20% (2) of member households in 5 months As of Q2 2020 Oak Street Health indicated less than 5% penetration (1) of total patients in its existing markets 1 year Time Source: Management reporting, Oak Street Health corporate presentation (October 2020). Notes: 1) ...and Early Evidence Suggests Babylon's Value Based Care Reduces Unplanned ER Visits... Home State Health - ER Visit Reduction Mar-21 Feb-21 Jan-21 Dec-20 Nov-20 Oct-20 31% Within 5 months Babylon obtained at least 1 registration from 584 of 3,169 households in its assigned population. Based on responses in the Alternative Health Choices survey (as part of consultation booking flow). Includes all VBC contracts in the US (i.e. Fresno, Home State Health). 47% 33% 44% 40% 50% Patients that booked digital consults said they would have used ER or Urgent Care (³) if Babylon's services had not been available ..Thus, Enabling Cost Savings and Driving the Profitability Increase Babylon VBC (4) – Gross Margin Improvement + 820 bps + 1,211 bps Q4-20 vs. Oct-20 Q1-21 vs. Oct-20 Babylon defines penetration as the receipt of registration from a household in its covered population. Oak Street Health and other companies in our industry may calculate penetration and similarly titled measures differently, which could reduce the usefulness of penetration as a tool for comparison. 74#75Financials Charlie Steel Chief Financial Officer 13.30#76Attractive Illustrative Economics of Babylon's Modular & Bundled Product Offerings Babylon VBC Clinical Services Software Licensing ● • ● ● ● Description Combines Babylon's digital health suite and virtual care platform to manage the totality of a patient's healthcare Takes full financial responsibility for all costs incurred in both primary, secondary and tertiary care settings, with stop loss protection Payment on a fixed and recurring capitation basis per covered life with ability to capture any cost savings On-screen consultations with a clinical professional Preventable and proactive care management Digital suite of Al and monitoring products Care navigation and non-clinical support available by live chat 1 I I T I I I I I I I I I I 1 I I Revenue Model PMPY Capitated model PMPM Fee-for-service I I Annual licensing fees! I Illustrative Revenue per Life Covered (1)(2) Thousands of Dollars Tens of Dollars Illustrative Example: Cents PMPY + Tens of Dollars Fee-For-Service Dollars ! Projection Based on Management Estimates (³) 1 I 1 I I I I I I I I I I I I Illustrative Gross Margin by Cohort(2) I I ~5% YO 17% (4) Case Study: Select UK Contracts Y1 30%+ -55% Y3 YO 25% (5) Case Study: Select Software Contract(6) Y3 90%+ Y1 Notes: 1) Management estimates based on active contracts. 2) Indicative proportions shown, as details are partner-specific. Gross profit reflects Revenue less Cost of Care Delivery. 3) Based on analysis vs VBC competitors with a brick & mortar model who lack front-end digital services and back-end digital automation services. 4) Gross Y1 (June 19 - June 20) Margin from select UK contract. 5) Average of select B2B contracts' Gross Margin over FY20. 6) Gross Margin as shown includes some technology costs that are classified as operating expenses in the company's financial projections. 76#77Babylon VBC Babylon VBC Captures Cost Savings Through Proactive Primary Care 100% Total Premium to Partner I Partner Margin & Admin costs Source: Management estimates. Note: Indicative proportions shown, as details are partner-specific. Partners pay Babylon a fixed capitation per covered life 1 -80% % Premium to Babylon Fixed, not shared cost savings model Extra Margin to Partner Babylon enables users to better manage their health and proactively provides highly cost-effective primary care 2 Primary Care Costs (Proactive Health Manager) Lowering the need for expensive, reactive secondary care cost 3 Secondary Care Costs Expanding Babylon's margin over time as expensive secondary care is replaced by efficient primary care 4 30%+ Total Babylon Margin 77#78Path to 2021E and 2022E Projected Revenue Based on Achievable and Visible Contract Pipeline of ~$3.6BN(¹) with Upside Potential Projected Revenue ($M) Annualization & Growth of Existing Contracts as of July 1, 2021(2) 2021 Converted Pipeline Contracts(3) 2022 Converted Pipeline Contracts (4) 2345 $79 2020A Revenue -$210 Reflects contracts signed between Apr-21 and Jun-21 -$32 ~90% delivered by contracts active as of 1 Jul-21 +10% increase since Apr-21 2021E Revenue Bridge -$321 Dec-20 ARR(5) -$170M 2021E Revenue -$118 ~$68 -$203 -70% delivered by contracts expected to be active as of 31 Dec-21 2022E Revenue Bridge Source: Management estimates. Management reporting. Notes: 1) Based on management estimates and a pipeline of contracts under discussion as of March 15, 2021. Reflects i) annualization and growth in existing contracts as of December 31, 2020 and ii) revenue from contracts active between December 31, 2020 and July 1, 2021. Reflects revenue impact of new business from converted pipeline contracts in 2021. Cohorts based on an illustrative set of contracts signed at varying points in time in 2021 with impact of annualization recognized in 2022. Reflects revenue impact of new business from converted pipeline contracts in 2022. Cohorts based on an illustrative set of contracts signed at varying points in time in 2022. Relevant December ARR (Annual Run-Rate Revenue) is calculated at a point in time by multiplying December revenue by 12. -$710 Dec-21 ARR(5) ~$475M 2022E Revenue 78#79Understanding Babylon's Pipeline 1) 2) 3) 4) 5) 6) Projected Revenue ($M) $79 Need to sign ~1 VBC contract in 2021 to achieve 2021E Revenue(¹) 2020A Revenue 2021E Revenue Bridge Total Pipeline Annual Value of Contracts split over 2 calendar years -$321 2021E Revenue 2022E Revenue Bridge -$710 $3.6BN ARR(6) 2022E Revenue Annualization & Growth of Existing Contracts as of July 1, 2021(3) Projected Revenue ($M) $79 Need to sign ~3 VBC contracts in 2022 to achieve 2022E Revenue(2) 2020A Revenue 2021E Revenue Bridge 2021 Converted Pipeline Contracts (4) ~50 Contracts -$321 2021E Revenue 2022E Revenue Bridge 2022 Converted Pipeline Contracts(5) Source: Management estimates and a pipeline of contracts under discussion as of March 15, 2021. Management reporting. Notes: Assumes i) contracts begin recognizing revenue in Q4 2021, and ii) deliver ARR of $130M based on the average VBC contract in the pipeline. Assumes i) contracts begin recognizing revenue in Q2 2022, and ii) deliver ARR of ~$130M based on the average VBC contract in the pipeline. Reflects i) annualization and growth in existing contracts as of December 31, 2020 and ii) revenue from contracts active between December 31, 2020 and July 1, 2021. Reflects revenue impact of new business from converted pipeline contracts in 2021. Cohorts based on an illustrative set of contracts signed at varying points in time in 2021 with impact of annualization recognized in 2022. Reflects revenue impact of new business from converted pipeline contracts in 2022. Cohorts based on an illustrative set of contracts signed at varying points in time in 2022. ARR (Annual Run-Rate Revenue) at the end of a given month is calculated at a point in time by multiplying that month's expected revenue by 12. -$710 2022E Revenue ~$130M Avg. ARR of VBC Contracts(6) 79#80Highly Recurring and Diversified Projected Revenue in 2021E Through 2023E Revenue breakdown 1234 Fixed vs Demand-Driven(1) 2021E 9% Demand-Driven Revenue Clinical Service: Fee-For-Service (FFS) OO 91% Fixed Revenue Babylon VBC: Capitation Fee License Fee: Fixed Fee or PMPM 3) 4) 2023E 3% Demand-Driven Revenue Clinical Service: FFS 97% Fixed Revenue Babylon VBC: Capitation Fee License Fee: Fixed Fee or PMPM Low volume risk 9% UK 2021E 4% Emerging Markets (2) Geography 3% Other Developed Markets (3) 84% US 2023E 6% Emerging Markets (2) 2% UK OO Focus on US 6% Other Developed Markets (3) 85% US Source: Management estimates. Notes: 1) Demand-driven revenue reflects revenue from Virtual Care contracts. Fixed revenue reflects revenue from Babylon VBC and Software contracts. Includes SE ASIA, China, LATAM, Rwanda, Middle East, Africa and India. 2) Includes Canada and Other Developed Markets (including Australia, New Zealand, Japan, and Continental Europe). Reflects the revenue breakdown by revenue stream, some contracts may combine multiple revenue streams e.g. Clinical Service contracts can include two revenue streams: FFS and a Licensing Fee. 10% License Fee 2021E Product (4) 9% Clinical Service: FFS 10% License Fee OO 2023E 81% VBC 3% Clinical Service: FFS 87% VBC Babylon VBC augmented by high-margin software licensing 80#81Revenue Growth Coupled with Gross Margin Expansion Year-over-Year Growth % 102% 394% 305% 121% 109% ($M) $16 2019A $79 Revenue 2020A 166% CAGR $321 2021E $710 2022E $1,484 2023E 99% ($M) $25 2019A Year-End ARR(1) Year-over-Year Growth % 581% 180% 104% 103% $170 2020A 126% CAGR $475 2021E Source: Management estimates. Notes: 1) Year-end ARR (Annual Run-Rate Revenue) is calculated at a point in time by multiplying December's expected monthly revenue by 12. Revenue less Cost of Care Delivery. 2) $967 2022E $1,960 2023E Gross Profit (2) % Gross Margin (24%) 15% 15% 18% 23% ($M) ($4) 2019A $12 2020A 204% CAGR $49 2021E $129 2022E $342 2023E 81#82We Expect Babylon's Margins to Expand as it Gains Operational Leverage $BN $1.6 $1.4 $1.2 $1.0 $0.8 $0.6 $0.4 $0.2 $0.0 ($0.2) We Expect Babylon will Grow Profitably... -Revenue Gross Margin (1) Adj. EBITDA (2) 2019A Source: Management estimates. Notes: 1) Revenue less Cost of Care Delivery. 2) 3) 2020A 2021E Constantly Improving Margins 2022E Adjusted EBITDA reconciliation on page 100. In 2020 95% of all bookings across Babylon's geographies were digital (including cancellations). CAGR 2020A-2023E: +166% Increasing Operating Leverage Margin: 23% Margin: 0% Medium-Term Target 2023E Gross Margin -30% EBITDA Margin -15% ...By Providing Digital-First End-to-End Care Babylon's highly-accessible, digital-first service will allow it to: Divert patients from expensive Urgent Care to proactive & accessible virtual primary care Avoid expensive downstream costs of chronic conditions by solving healthcare issues earlier ...and Reducing Expensive Delivery Costs Leverage technology and automation to significantly reduce the cost of primary care: Increase in efficiency by automating admin and other lower-value tasks Use digital triage to increase the proportion of interactions served by lower-cost healthcare professionals Reducing costs associated with physical services by solving -95%(³) of issues via digital consultations 82#83Historical and Projected Financial Summary $M Revenue % growth Gross Profit(1) % growth % margin Adj. EBITDA (²) % margin Source: Management estimates. Notes: 1) Revenue less Cost of Care Delivery. 2) Adjusted EBITDA reconciliation on page 100. HISTORICAL 2019A 16 102% (4) (24%) (152) 2020A 79 394% 12 15% (142) ‒‒‒‒‒ 2021E 321 305% 49 299% 15% (140) (44%) - PROJECTED ‒‒‒ 2022E 710 121% 129 166% 18% (119) (17%) I ‒‒‒‒‒ 2023E 1,484 109% 342 165% 23% 5 0% 83#84Babylon's Growth Levers#85Babylon has Multiple Value-Accretive Growth Levers Note: M&A not included in base business financial forecasts 1 Potential Addressable Market for Existing Customers(1) 2 ● Potential to expand covered population with existing customers Potential to increase scope of contract to a full capitation construct through Babylon VBC Expanding Babylon's Geographic Coverage with Existing Customers (2) Potential Addressable Market for Existing Covered Populations (³) Dec-20 ARR(4) for Existing Contracts ~$50BN -$5BN ~$170M Strong Contract Pipeline Strong track record of winning new contracts worldwide Over $3.5BN of additional aggregated ARR possible in the pipeline through existing customers and new business Existing Clients New Clients Total Pipeline Projected ARR(4) -$1.2BN -$2.4BN -$3.6BN 3 ● Targeted Acquisitions & Strategic Investments Opportunity to consolidate brick & mortar, integrated care providers in the US Acquiring new partners to augment Babylon's end-to-end platform Consolidation Gij Example Completed Deal higi Technology & Content (5) Distribution Omni-channel consumer health engagement platform with nationwide retail network of 10,000 FDA-cleared, free-to-use Smart Health Stations which help identify health risks and match consumers to care Source: Based on management estimates and a pipeline of contracts under discussion as of March 15, 2021. Notes: 1) Reflects potential addressable market based on existing clients including contracts not currently in the pipeline. Market size based on annualized monthly revenue of potential new contracts with existing customers. 2) Addressable market for Babylon VBC based on lives covered by Babylon's existing clients. Calculated using an illustrative Babylon VBC PMPY pricing assumption based on management's current discussions and market knowledge; number of lives based on managements best estimates. 3) Assumes Babylon's existing clients with software license contracts purchase either fee-for-service or Babylon VBC for the lives covered under their existing contracts based on management's expectations. Assumes Babylon's existing clients with fee-for-service contracts purchase Babylon VBC for lives covered under their existing contracts. Calculated using illustrative pricing assumptions based on management's current discussions and market knowledge. 4) ARR (Annual Run-Rate Revenue) at the end of a given month is calculated at a point in time by multiplying that month's expected revenue by 12. 5) Babylon owns a 22% equity stake in Higi. 85#861 Significant Opportunity Within Existing Customer Base Potential Addressable Market for Existing Customers(1) Expanding Babylon's Geographic Coverage with Existing Customers(²) Potential Addressable Market for Existing Covered Populations (3) Dec-20 ARR for Existing Contracts (4) ~$50BN ~$5BN ~$170M Potential Upsell Historical Upsell Based on Contracts Pipeline in the Case Study: Large US Payor Potential upsell opportunity with one payor based only on contracts already in discussion and in the pipeline(5) Jun-2020 Dec-2020 Dec-2023 Total ARR(4) ~$6M ~$55M ~$700M+ Products Software Clinical Licensing Services Software Clinical Licensing Services Software Clinical Licensing Services (22 VBC VBC Source: Based on management estimates and a pipeline of contracts under discussion as of March 15, 2021. Notes: 1) Reflects potential addressable market based on existing clients including contracts not currently in the pipeline. Market size based on annualized monthly revenue of potential new contracts with existing customers. 2) Addressable market for Babylon VBC based on lives covered by Babylon's existing clients. Calculated using an illustrative Babylon VBC PMPY pricing assumption based on management's current discussions and market knowledge; number of lives based on managements best estimates. 3) Assumes Babylon's existing clients with software license contracts purchase either fee-for-service or Babylon VBC for the lives covered under their existing contracts based on management's expectations. Assumes Babylon's existing clients with fee-for-service contracts purchase Babylon VBC for lives covered under their existing contracts. Calculated using illustrative pricing assumptions based on management's current discussions and market knowledge. 4) ARR (Annual Run-Rate Revenue) at the end of a given month is calculated at a point in time by multiplying that month's expected revenue by 12. 5) Based on management estimates and contracts under discussion as of March 15, 2021. 86#872 Strong Pipeline of New Clients Worldwide Projected ARR(1) Pipeline Coverage (2) Deal Count Upselling Existing Clients -$1.2BN -98% VBC 2.5x ~15 -55% VBC New Clients ~$2.4BN -99% VBC 5.1x -35 -55% VBC Source: Based on management estimates and a pipeline of contracts under discussion as of March 15, 2021. Notes: 1) ARR (Annual Run-Rate Revenue) at the end of a given month is calculated at a point in time by multiplying that month's expected revenue by 12. 2) Multiple of estimated December 2021 Annual Run-Rate Revenue of $475M. Total Pipeline -$3.6BN ~99% VBC 7.6x -50 -55% VBC 87#883 We Believe Babylon can Bolster Breadth of Offerings Through Targeted Acquisitions Consolidation Plan to acquire legacy integrated care networks and improve their economics through highly scalable digital-first platform and provide access to new network of consumers and providers Notes: 1) 2) Example Completed Deal FirstChoice MEDICAL GROUP New Medicaid and Medicare Advantage Plans Babylon owns a 22% equity stake. Babylon bought a majority stake in DayToDay, which is subject to re-purchasing rights. Distribution Plan to increase customer touch points and explore new or augmented existing distribution channels Example Completed Deal (¹) Ⓒhigi Retail Outlet Deployment Technology & Content Plan to acquire tools and platforms that enhance Babylon's ability to deliver best-in- class digital-first care Example Completed Deal (2) & daytoday New Geographies 88#89Financial Deep Dive#90Clinical Service Software F Licensing Babylon VBC Revenue Model Review Revenue Methodology Cost Methodology Example Customer Value Based Care Via Babylon 360 Capitation Revenue Per Member Per Month ("PMPM")(1) Assume the financial responsibility for the healthcare expenses of members CENTENEⓇ Corporation Home State Health Clinical Services License Fee (PMPM) + Fee-for-Service ("FFS") Clinical Costs + Incremental Software Cost (minimal cost) вирал (Leading UK Insurer) Software Licensing Via Babylon Cloud Services Upfront Fee (revenue recognized over the contract term) Incremental Software Cost (minimal cost) P PRUDENTIAL TELUS Note: Reflects typical contracts under each Babylon product, however, specific contracts terms may vary. 1) Significant portion of the PMPM fee is fixed, and the remainder of the PMPM fee is variable. Revenue from the variable PMPM fees can be earned through either, or a combination of, the achievement of certain performance metrics or the realization of healthcare savings resulting from the utilization of our services. 90#91Babylon VBC Babylon VBC: Capitation Review Babylon VBC Revenue Profit 1 2 Monthly Reimbursement per Member 3 3 4 5 6 Contract Lives Note: 1) Illustrative PMPM for a Babylon VBC contract Total Monthly Contract Revenue Total Monthly Contract Revenue Primary Healthcare Costs Secondary & Tertiary Costs || Monthly Contract Profits ~10K Lives .......... -$150 PMPM(1) (Per Member Per Month) -$1.5M MRR (Monthly Recurring Revenue Received over Contract Term) Illustrative Example Babylon VBC revenue is recognized consistently over the contract term Babylon provides efficient and cost-effective primary care... ...lowering the need for more expensive, reactive secondary & tertiary care Stop loss provision of contracts ensures floored $ amount risk, enabling maximization of profits 91#92Consolidated Statement of Profit and Loss For the Years Ended December 31, $ in thousands Revenue 1 Cost of Care Delivery 2 R&D and Technology Expenses 3 Sales, General & Administration Expenses Operating Loss Net Finance Costs Exchange Rate Gains/ (Losses)(1) Share of Loss of Equity-accounted Investees Loss Before Taxation Tax Benefit/ (Provision) Net Loss 2019A 16,034 (19,810) (68,153) (90,891) (162,820) (101) 17,075 (145,846) 5,559 (140,287) 2020A 79,272 (67,254) (84,188) (175,511) (103,341) 2 Employee-related expenses (salaries, bonuses, stock-based compensation expense, training expenses and benefits for employees and contractors in our technology department); includes tax credits relating to our R&D activities and the amortization of capitalized development costs; largely fixed expense base growing commensurate with ongoing maintenance and continued development (3,920) (2,836) (1,124) (183,391) (4,639) (188,030) Primary Drivers 1 Fees paid to providers/health professionals plus costs incurred in connection with provider network operations; recorded as an expense when VBC revenue is recognized - largely variable driven by member activity and required medical services 3 Employee-related expenses, contractors and consultants' expense, stock-based compensation, property and facility related expenses, IT and hosting, marketing, training and recruiting expenses; includes depreciation of property, fixtures and fittings and amortization of acquired intangible assets; largely fixed expense base with expense growth associated with incremental costs as a new public company and other business growth related expense Source: Management reporting. Note: 1) Gain includes those resulting from inter-company relationships with significant GBP balances within USD companies translated at rates in accordance with IFRS. 92#93Consolidated Statement of Profit and Loss (Cont'd) For the Years Ended December 31, $ in thousands Revenue 1 Cost of Care Delivery 2 R&D and Technology Expenses 3 Sales, General & Administrative Expenses Operating Loss 4 Net Finance Costs 5 Exchange Rate Gains/ (Losses)(1) Share of Loss of Equity-accounted Investees Loss Before Taxation 6 Tax Benefit / (Provision) Net Loss 2019A 16,034 (19,810) (68,153) (90,891) (162,820) (101) 17,075 (145,846) 5,559 (140,287) 2020A 79,272 (67,254) (84,188) (103,341) (175,511) (3,920) (2,836) (1,124) (183,391) (4,639) (188,030) 1 Increase in 2020 following launch of Value Based Care services in US; further increases in the UK, Canada and Rwanda due to increased demand for appointments 2 3 4 Summary of Historical Performance 6 Increase in 2020 due to increased amortization following the launch of Licensing services in Asia and the US; technology headcount reduction in 2020 following mid- year restructuring Increase in 2020 due to higher headcount in commercial and support services aligned to business growth; increased professional fees from FCMG acquisition and deployment of Babylon services into new markets Finance costs relate primarily to lease obligations and the accounting for certain Licensing services when upfront payments are received from customers 5 Exchange rate loss primarily due to fluctuation between USD and GBP (majority of Babylon revenue received in USD, majority of expenses paid in GBP); exchange rate gain in 2019 results from majority of business operating in GBP despite the functional currency being USD The change in tax (provision)/benefit is primarily the reversal of previously recognized tax benefits of $4.3M related to U.K. tax credits for qualifying R&D activities, which will be amortized over the useful life of the related capitalized development costs as a reduction to R&D technology expense Source: Management reporting. Note: 1) Gain includes those resulting from inter-company relationships with significant GBP balances within USD companies translated at rates in accordance with IFRS. 93#94Adjusted EBITDA Reconciliation $ in millions Net Loss 1 (+) Depreciation & Amortization 2 (+) Net Finance Costs 3 (+) Tax EBITDA 4 (+) Impairment 5 (+) Share Based Payments 6 (+) Exchange Rate (Gains) / Losses Adjusted EBITDA 2019A (140.3) 2.5 0.1 (5.6) (143.2) 8.0 (17.1) (152.4) 2020A (188.0) 14.5 3.9 4.6 (165.0) 6.4 1 2 (146.2) 3 Commentary Increased amortization of capitalized technology costs as a result of new software licence contracts Primarily the reversal of previously recognized tax benefits related to U.K. tax credits for qualifying R&D activities, which will be amortized over the useful life of the related capitalized development costs as a reduction to R&D technology expense 4 Impairment of technology development costs 2.8 6 Finance costs relate primarily to lease obligations and the accounting for certain Licensing services when upfront payments are received from customers 9.6 5 Share based compensation relating to employees Exchange rate loss primarily due to fluctuation between USD and GBP (majority of Babylon revenue received in USD, majority of expenses paid in GBP); exchange rate gain in 2019 results from majority of business operating in GBP despite the functional currency being USD Source: Management reporting. Notes: We have not reconciled the non-IFRS measures for the future periods to their corresponding IFRS measures because certain reconciling items such as share-based payments and exchange rate gains and losses depend on factors such as the share price at the time of award of future grants and foreign exchange rates and thus cannot be reasonably predicted. Accordingly, reconciliation to the non-IFRS projected measures are not available without unreasonable effort. 94#95Condensed Consolidated Statement of Cash Flows For the Years Ended December 31, $ in thousands Cash Flow from Operating Activities Adjusted EBITDA 1 Share of Net Loss of Associates 2 Net Working Capital Adjustments Net Cash Used in Operating Activities Cash Flow from Investing Activities 3 Development Costs Capitalized 4 Payment for Acquired Trade Assets 5 Purchase of Shares in Associates Purchase of PPE Interest Received Net Cash Used in Investing Activities 6 Cash Flow from Financing Activities Proceeds from Issuance of Convertible Loan Notes Repayment of Loans Net Proceeds from Issuance of Share Capital Other Net Cash Provided by Financing Activities Cash and Cash Equivalents at January 1, Net (Decrease) / Increase in Cash and Cash Equivalents Effect of Movements in Exchange Rate on Cash Held Cash and Cash Equivalents at December 31, Source: Management reporting. 2019A 2020A (152,358) 8,744 (143,614) (36,036) (1,915) 1,015 (36,936) 51,064 (16,025) 319,561 (2,079) 352,251 46,031 171,971 (3,114) 214,888 (146,155) 1,124 1,601 (143,430) (36,509) (25,671) (10,000) (719) 673 (72,226) 100,000 1,851 (1,793) 100,058 214,888 (115,598) 2,467 101,757 Commentary 1 Relates to Babylon's investment in Higi 2 Greater portion of revenue was recognized from advanced payments from Licensing 3 Consistent with 2019, slight increase as a result of higher amortization and the mid-year restructure 4 Investments in a controlling stake in First Choice Medical Group 5 Investment in Higi 6 Issuance of $100M worth of convertible loan notes in 2020, which were converted into equity in two tranches, with $30M converting in December 2020 and $70M converting in June 2021 95#96Condensed Consolidated Statement of Financial Position As of December 31, $ in thousands Non-Current Assets Right-of-use Assets + PPE Goodwill and Investments in Associates Other Intangible Assets Total Non-Current Assets Current Assets Prepayments, Receivables and Other Cash and Cash Equivalents Other Total Current Assets Total Assets Source: Management reporting. 2019A 7,030 61 43,751 50,842 23,104 214,888 237,992 288,834 2020A 3,906 26,708 78,853 109,467 22,366 101,757 5,224 129,347 238,814 As of December 31, $ in thousands Equity Share Related Reserves Retained Earnings Translation Differences Total Capital and Reserves Non-Controlling Interest Total Equity Liabilities Contract & Lease Liabilities Other Total Non-Current Liabilities Loans & Borrowings Other Current Liabilities Total Current Liabilities Total Liabilities Total Liabilities & Equity 2019A 458,406 (282,705) (1,904) 173,797 173,797 68,477 68,477 46,560 46,560 115,037 288,834 2020A 517,419 (469,504) 1,675 49,590 (1,231) 48,359 59,285 7,488 66,773 70,357 53,325 123,682 190,455 238,814 96#97De (1-C N ds² Thank you babylon#98Appendix#99Glossary Term A&E AI ARR B2B CAGR EBITDA ER GP GTM Definition Accident & Emergency Artificial Intelligence Annual Run-Rate Revenue Business to Business Compounded Annual Growth Rate Earnings Before Interest Tax Depreciation & Amortisation Emergency Room General Practitioner Go-to-market Term HSH NHS QOF PIPE PMPM PMPY RWT SaaS TEV VBC Definition Home Street Health National Healthcare Service Quality Outcomes Framework Private Investment in Public Equity Per Member Per Month Per Member Per Year The Royal Wolverhampton NHS Trust Software as a Service Total Enterprise Value Value Based Care 99#100Risk Factors Summary 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. We have a history of net losses, we anticipate increasing expenses in the future, and we may not be able to achieve or maintain profitability. Our relatively limited operating history makes it difficult to evaluate our current business and future prospects and increases the risk of your investment. If we fail to effectively manage our growth, we may be unable to execute our business plan, adequately address competitive challenges or maintain our corporate culture, and our business, financial condition and results of operations would be harmed. Our business and growth strategy depend on our ability to maintain and expand a network of qualified providers. If we are unable to do so, our future growth would be limited and our business, financial condition and results of operations would be harmed. We are dependent on our relationships with physician-owned entities, which are affiliated professional entities that we do not own, to hold contracts and provide healthcare services, and our business would be harmed if those relationships were disrupted. If we are unable to attract new customers and expand member enrollment with existing customers, our revenue growth could be dower than we expect, and our business may be adversely affected. If our existing customers do not continue or renew their contracts with us, renew at lower fee levels or decline to purchase additional applications and services from us, it could have a material adverse effect on our business, financial condition and results of operations. Our revenue sources are highly concentrated, the loss of any of which would have a material adverse effect on our business, financial condition and results of operations. Under many of our agreements with health plans, we assume some or all of the risk that the cost of providing services will exceed our compensation. Over time, we expect the proportion of risk-based revenue may increase. We may face intense competition, which could limit our ability to maintain or expand market share within our industry, and if we do not maintain or expand our market share our business and operating results will be harmed. If we are not able to develop and release new solutions and services, or successful enhancements, new features and modifications to our existing solutions and services, our business could be adversely affected. There are significant risks associated with estimating the amount of revenue that we recognize under our risk-based agreements with health plans, and if our estimates of revenue are materially inaccurate, it could impact the timing and the amount of our revenue recognition or have a material adverse effect on our business, financial condition, results of operations and cash flows. Security breaches, loss of data and other disruptions could compromise sensitive information related to our business or members, or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and our reputation. Our use, disclosure, and other processing of personally identifiable information, including health information, is subject to HIPAA, the GDPR and the DPA 2018, and other privacy and security regulations, and our failure to comply with those regulations or to adequately secure the information we hold could result in significant liability or reputational harm and, in turn, a material adverse effect on our client base, member base and revenue. If we are unable to obtain, maintain and enforce intellectual property protection for our technology or if the scope of our intellectual property protection is not sufficiently broad, others may be able to develop and commercialize technology substantially similar to ours, and our ability to successfully commercialize our technology may be adversely affected. We may become subject to medical liability claims, which could cause us to incur significant expenses and may require us to pay significant damages if not covered by insurance. We have been and may in the future become subject to litigation or regulatory investigation, which could harm our business. We rely on internet infrastructure, bandwidth providers, third-party computer hardware and software and other third parties for providing services to our customers and members, and any failure or interruption in the services provided by these third parties could expose us to litigation and negatively impact our relationships with customers and members, adversely affecting our operating results. We conduct business in a heavily regulated industry and if we fail to comply with these laws and government regulations, we could incur penalties or be required to make significant changes to our operations or experience adverse publicity, which could have a material adverse effect on our business, financial condition, and results of operations. The impact of recent healthcare reform legislation and other changes in the healthcare industry and in healthcare spending on us is currently unknown, but may adversely affect our business, financial condition and results of operations. We depend on our talent to grow and operate our business, and if we are unable to hire, integrate, develop, motivate and retan our personnel, we may not be able to grow effectively. 100